Merrimack stock rockets 200% after positive trial data on Onivyde pancreatic cancer treatment
This entry was posted by admin on November 9, 2022 at 7:57 pm
- Tags:
$200, after, Cancer, data, Merrimack, Onivyde, pancreatic, positive, rockets, Stock, treatment, trial
- Categories:
Breaking
Comments
Comments are disabled for this post.